Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
International Journal of Cardiology
|
June 21, 2012
Renal complications correlate with electrical atrial vulnerability hallmarks in type 2 diabetic patients
D Montaigne, O Bailloeuil, C Hulin-Delmotte, et al.
Diabetes & Metabolism
|
November 18, 2006
Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study
L Dufaitre-Patouraux, J P Riveline, E Renard, et al.
Diabetes & Metabolism
|
October 22, 2013
Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?
S Franc, S Borot, O Ronsin, et al.
Diabetes & Metabolism
|
September 18, 2012
Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE
P-Y Benhamou, B Catargi, B Delenne, et al.
Annals of Internal Medicine
|
May 1, 2001
Maternally inherited diabetes and deafness: a multicenter study
P J Guillausseau, P Massin, D Dubois-LaForgue, et al.
Diabetes & Metabolism
|
June 30, 2004
Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD)
P J Guillausseau, D Dubois-Laforgue, P Massin, et al.
Diabetes & Metabolism
|
November 28, 2017
Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement
S Borot, P Y Benhamou, C Atlan, et al.
Diabetologia
|
June 27, 2008
Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study
P Massin, D Dubois-Laforgue, T Meas, et al.
Diabetes & Metabolism
|
November 5, 2020
Practical implementation of automated closed-loop insulin delivery: A French position statement
N Tubiana-Rufi, P Schaepelynck, S Franc, et al.
Diabetes & Metabolism
|
March 12, 2025
Practical implementation of automated insulin delivery systems in 2025: A French position statement update
E Bismuth, M Joubert, E Renard, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
International Journal of Cardiology
|
June 21, 2012
Renal complications correlate with electrical atrial vulnerability hallmarks in type 2 diabetic patients
D Montaigne, O Bailloeuil, C Hulin-Delmotte, et al.
Diabetes & Metabolism
|
November 18, 2006
Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study
L Dufaitre-Patouraux, J P Riveline, E Renard, et al.
Diabetes & Metabolism
|
October 22, 2013
Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?
S Franc, S Borot, O Ronsin, et al.
Diabetes & Metabolism
|
September 18, 2012
Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE
P-Y Benhamou, B Catargi, B Delenne, et al.
Annals of Internal Medicine
|
May 1, 2001
Maternally inherited diabetes and deafness: a multicenter study
P J Guillausseau, P Massin, D Dubois-LaForgue, et al.
Diabetes & Metabolism
|
June 30, 2004
Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD)
P J Guillausseau, D Dubois-Laforgue, P Massin, et al.
Diabetes & Metabolism
|
November 28, 2017
Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement
S Borot, P Y Benhamou, C Atlan, et al.
Diabetologia
|
June 27, 2008
Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study
P Massin, D Dubois-Laforgue, T Meas, et al.
Diabetes & Metabolism
|
November 5, 2020
Practical implementation of automated closed-loop insulin delivery: A French position statement
N Tubiana-Rufi, P Schaepelynck, S Franc, et al.
Diabetes & Metabolism
|
March 12, 2025
Practical implementation of automated insulin delivery systems in 2025: A French position statement update
E Bismuth, M Joubert, E Renard, et al.
Page
of 10